Difference between revisions of "Team:TCU Taiwan/Result/Peptides"
Line 91: | Line 91: | ||
<div id="st1" class="st"> | <div id="st1" class="st"> | ||
<div class="inner"> | <div class="inner"> | ||
+ | In Epinecidin-1, concentration of 1ul, we can see the most significant effectiveness. | ||
+ | <br> | ||
<table width="95%" align="center"> | <table width="95%" align="center"> | ||
<tr> | <tr> | ||
<td width="80%"align="center"><h1><span style="font-family:Calibri;text-align:justify;"><font size="5"> | <td width="80%"align="center"><h1><span style="font-family:Calibri;text-align:justify;"><font size="5"> | ||
− | + | ||
<img src="https://static.igem.org/mediawiki/2015/7/74/2015tcutaiwan11.jpg" width="70%" align="center" /></br></br> | <img src="https://static.igem.org/mediawiki/2015/7/74/2015tcutaiwan11.jpg" width="70%" align="center" /></br></br> | ||
<img src="https://static.igem.org/mediawiki/2015/f/f0/Tcu_TaiWAn_ResUlt_2.jpeg" width="70%" align="center" /></br></br> | <img src="https://static.igem.org/mediawiki/2015/f/f0/Tcu_TaiWAn_ResUlt_2.jpeg" width="70%" align="center" /></br></br> | ||
Line 101: | Line 103: | ||
<img src="https://static.igem.org/mediawiki/2015/b/bd/Tcu_TaiWAn_ResUlt_4.jpeg" width="70%" align="center" /></br></br> | <img src="https://static.igem.org/mediawiki/2015/b/bd/Tcu_TaiWAn_ResUlt_4.jpeg" width="70%" align="center" /></br></br> | ||
<img src="https://static.igem.org/mediawiki/2015/4/4e/Tcu_TaiWAn_ResUlt_5.jpeg" width="70%" align="center" /></br></br> | <img src="https://static.igem.org/mediawiki/2015/4/4e/Tcu_TaiWAn_ResUlt_5.jpeg" width="70%" align="center" /></br></br> | ||
+ | </font></span></h1></td> | ||
+ | </tr> | ||
+ | </table> | ||
+ | <br> | ||
In Signiferin, concentration of 50<span style="font-family:Symbol;"></span>l, we can see the most significant effectiveness. | In Signiferin, concentration of 50<span style="font-family:Symbol;"></span>l, we can see the most significant effectiveness. | ||
+ | <br> | ||
+ | <table width="95%" align="center"> | ||
+ | <tr> | ||
+ | <td width="80%"align="center"><h1><span style="font-family:Calibri;text-align:justify;"><font size="5"> | ||
<img src="https://static.igem.org/mediawiki/2015/7/78/Tcu_TaiWAn_ResUlt_6.jpeg" width="70%" align="center" /></br></br> | <img src="https://static.igem.org/mediawiki/2015/7/78/Tcu_TaiWAn_ResUlt_6.jpeg" width="70%" align="center" /></br></br> | ||
<img src="https://static.igem.org/mediawiki/2015/b/b4/Tcu_TaiWAn_ResUlt_7.jpeg" width="70%" align="center" /></br></br> | <img src="https://static.igem.org/mediawiki/2015/b/b4/Tcu_TaiWAn_ResUlt_7.jpeg" width="70%" align="center" /></br></br> | ||
Line 108: | Line 118: | ||
<img src="https://static.igem.org/mediawiki/2015/3/3a/Tcu_TaiWAn_ResUlt_9.jpeg" width="70%" align="center" /></br></br> | <img src="https://static.igem.org/mediawiki/2015/3/3a/Tcu_TaiWAn_ResUlt_9.jpeg" width="70%" align="center" /></br></br> | ||
<img src="https://static.igem.org/mediawiki/2015/8/81/2015tcutaiwan10.jpg" width="70%" align="center" /></br></br> | <img src="https://static.igem.org/mediawiki/2015/8/81/2015tcutaiwan10.jpg" width="70%" align="center" /></br></br> | ||
+ | </font></span></h1></td> | ||
+ | </tr> | ||
+ | </table> | ||
+ | <br> | ||
In Epinecidin-1 and Signiferin, concentration of 1<span style="font-family:Symbol;"></span>l, we can see the most significant effectiveness.</br> | In Epinecidin-1 and Signiferin, concentration of 1<span style="font-family:Symbol;"></span>l, we can see the most significant effectiveness.</br> | ||
+ | |||
+ | <table width="95%" align="center"> | ||
+ | <tr> | ||
+ | |||
+ | <td width="80%"align="center"><h1><span style="font-family:Calibri;text-align:justify;"><font size="5"> | ||
+ | |||
<img src="https://static.igem.org/mediawiki/2015/a/a4/2015tcutaiwan12.jpg" width="70%" align="center" /></br></br> | <img src="https://static.igem.org/mediawiki/2015/a/a4/2015tcutaiwan12.jpg" width="70%" align="center" /></br></br> | ||
<img src="https://static.igem.org/mediawiki/2015/e/ed/2015tcutaiwan13.jpg" width="70%" align="center" /></br></br> | <img src="https://static.igem.org/mediawiki/2015/e/ed/2015tcutaiwan13.jpg" width="70%" align="center" /></br></br> |
Revision as of 01:12, 19 September 2015
To indirect prove wound healing, we perform experiments in cell migration. Two cells are selected for the experiment: Squamous keratinocyte called HaCat, and Dermal microvascular endothelium cell called HMEC-1. To make the result closer to human, both cells were sampled from human cells. Squamous keratinocyt cell shows the influence of our peptides on epithelial. On other hand, because angiogenesis is one of the indicators of wound healing, Dermal microvascular endothelium cell is selected here. In cell migration experiment, samples are divided into following groups:1. Mock2. pQE-60 has no insert and no IPTG induction of LB medium for 200 l (Control 1)3. pQE-60 has insert, without IPTG induction of LB medium for 200 l (Control 2)4. pQE-60 has no insert, with IPTG induction of LB medium for 200 l (Control 3)5. 1l AMPs 6. 5l AMPs7. 100l AMPs8. 200l AMPsFurthermore, all of above groups are divided into three more groups: Epinecidin-1, Signiferin, Epinecidin-1 and Signiferin. |
In Epinecidin-1, concentration of 1ul, we can see the most significant effectiveness.
In Signiferin, concentration of 50l, we can see the most significant effectiveness.
In Epinecidin-1 and Signiferin, concentration of 1l, we can see the most significant effectiveness.
In Signiferin, concentration of 50l, we can see the most significant effectiveness.
In Epinecidin-1 and Signiferin, concentration of 1l, we can see the most significant effectiveness.
After cell migration experiment, To interpret our result, we use ImageJ to distance measurement and compare them. |
Contact us tcutaiwan@gmail.com No.701, Sec. 3, Zhongyang Rd. Hualien 97004, Taiwan |